A new CAR-T-cell therapy tricks cancer cells with a decoy to increase treatment efficiency in B-cell Acute Lymphoblastic Leukaemia

CAR-T cell therapy has significantly improved outcomes for B-ALL patients, but relapse still occurs in over 50% of cases, leaving many with limited treatment options. Ongoing research aims to address this challenge and improve CAR-T therapy effectiveness.

Read more: https://www.cnio.es/en/news/a-new-car-t-cell-therapy-tricks-cancer-cells-with-a-decoy-to-increase-treatment-efficiency-in-b-cell-acute-lymphoblastic-leukaemia/